In a study published in Proceedings of the National Academy of Sciences, the Love Lab designed an AI model for more efficient yeast-based production of protein drugs for the treatment of cancer and other diseases.Led by former postdoc and Mazumdar-Shaw International Oncology Fellow Harini Narayanan, the researchers used the Love Lab's yeast-based biomanufacturing platform to develop a large language model that optimizes genetic sequences for protein production—an unpredictable part of advancing new biologic drugs to the clinic.The study reflects Love's longstanding interest in improving both small- and industry-scale drug manufacturing processes. His perspectives as co-director of the new MIT Initiative for New Manufacturing are featured in the MIT Technology Review.